# University Hospital of Salamanca / IBSAL

Source: https://onco.cc/institutions/hospital-universitario-salamanca/  
OnCo record `hospital-universitario-salamanca` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Spanish university hospital whose haematology department, home of María-Victoria Mateos and the Spanish Myeloma Group, led the trials that defined treatment of smouldering and newly diagnosed myeloma.

## Summary

The University Hospital of Salamanca and its research institute IBSAL form one of Europe's leading myeloma centres. Its haematology department, long associated with Jesús San Miguel and now with María-Victoria Mateos, coordinates the Spanish Myeloma Group (GEM/PETHEMA) and led the trials of lenalidomide in high-risk smouldering myeloma, the ALCYONE trial of daratumumab in transplant-ineligible patients and the flow cytometry methods for measuring minimal residual disease.

## Fields

- Kind: Institution
- Last checked: 2026-09-18
- Also known as: Hospital Universitario de Salamanca; Complejo Asistencial Universitario de Salamanca; Instituto de Investigación Biomédica de Salamanca
- City: Salamanca, ES
- Type: hospital

## Connected records

- cancers: [Multiple myeloma](https://onco.cc/cancers/multiple-myeloma/)
- people: [María-Victoria Mateos](https://onco.cc/people/maria-victoria-mateos/)

---
JSON: https://onco.cc/api/v1/entities/hospital-universitario-salamanca.json